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The I  region of the murine major histocompatibility complex (H-2) l was first defined by 
immune  response  (Ir)  genes governing antibody synthesis to chemically defined antigens in 
inbred mice (I, 2).  Recent studies suggest that other immunoregulatory genes are localized to 
this  region as well.  Specifically, T-B  cell collaboration in  antibody production  (3),  macro- 
phage-T-cell interaction (4),  proliferation in mixed lymphocyte culture (5),  graft-versus-host 
reactivity (6, 7), virus susceptibility (8), and antigenic determinants on suppressor T  cells (9), 
as well as suppressive (10) and enhancing factors (11) are governed by I-region genes. Because 
of the importance of immunoregulatory genes, great interest currently centers on I-region gene 
product identification. 
Reciprocal immunization between I-region congenic mice (12-15)  has revealed a  complex 
system of I-region-associated (Ia) antigens (16).  Their expression is confined to lymphocytes, 
macrophages, and epidermal and sperm cells (17). If Ia antigens or the cells which express them 
are involved in immunoregulation, it appears paradoxical that these antigens have been found 
predominantly on B cells (12-18), since immunoregulatory functions (Ir genes) are expressed in 
T  cells  (2).  Initially, a  controversy  existed  regarding  T-cell  Ia  antigen  expression;  some 
investigators were able to demonstrate Ia-positive T cells (12,  13, 15), whereas others could not 
(14,  18-20).  Subsequent  results suggest that a T-cell subpopulation bears Ia determinants in 
diminished density compared to B cells (21-25). 
Limited evidence suggests restricted expression of certain Ia specificities to cells of either B or 
T lineage, whereas others are common to both. Specificities Ia. 1-Ia. 10 appear indistinguishable 
on T  and  B  blasts  (23,  26).  On  the other hand,  I-J  region specificities have been  detected 
exclusively on T cells (9). Thus, while several Ia antigens are common to B and T lymphocytes, 
others are unique to one or the other cell type. 
The  findings that  there are Ia antigens restricted in thymus-derived cells (9,  25), 
and that  a  minor fraction of peripheral T  Ceils express Ia antigens in lower density 
than peripheral B cells (21-24), may explain the observed discrepancies regarding T- 
cell  Ia  antigen  expression  (12-20).  If the  antisera  employed  varied either  in  titer, 
antibody-antigen affinity, or  in  content  of relevant T-cell Ia antibody by virtue of 
differing immunization protocols or I subregions studied, conflicting results might be 
expected. 
We have employed an  alternative approach to the study of T-cell Ia antigens.  I- 
region disparate mice were immunized with an Ia-positive T-cell population, concan- 
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H-2 Region 
Haplotype  Strain  K  I  S  G  D 
A  B  J  E  C 
II-2  i:j  BI0.A(3R)  b  b  b  b  k  d  d  d  d 
II-2  it'  BI0.A(5R)  b  b  b  k  k  d  d  d  d 
11-2  ta  BI0.ItTT  s  s  s  s  k  k  k  k  d 
II-2  h  B10  b  b  b  b  b  b  b  b  b 
11-2  a  BI0.D2  d  d'  d  d  d  d  d  d  d 
It-2  k  BI0.BR  k  k  k  k  k  k  k  k  k 
ti-2"  BI0.S  s  s  s  s  s  s  s  s  s 
I1-2  q  BI0.G  q  q  q  q  q  q  q  q  q 
avalin A  (Con A)-stimulated thymocyte blasts (26-28). The genetic disparity between 
donor, B10.A(5R), and recipient mice, (B10  ×  B10.D2)F1, was restricted to the I-J 
and I-E subregions of the H-2 complex (9, 29). The H-2 haplotypes of origin of strains 
used  in  this  study  are  given in Table  I.  This  immunization protocol  produced  a 
strikingly T-cell-specific anti-I-JkE  k serum of high titer and limited haplotype cross- 
reactivity. These results and implications for Ia antigen serology are discussed. 
Materials and Methods 
Mice.  Mice were obtained from our colony at the University of Wisconsin. Both male and 
female animals were used, 
Media.  All media and supplements were obtained from Grand Island Biological Co., Grand 
Island, N. Y., except as otherwise noted. 
Con A Stimulation of Thymocytes.  Thymuses were removed from asphyxiated 4-6-wk-old mice 
into cold Hanks' balanced salt solution. Capsular tissue was carefully removed, the thymus was 
teased  gently apart  using a  needle and forceps,  and a  single cell  suspension was prepared. 
Thymocyte blasts were prepared according to David et al. (26). Briefly, cells were suspended 
(10-15 ×  106/ml) in 25 mM Hepes-buffered RPMI-1640 containing fetal calf serum (2.5%), 2- 
mercaptoethanol (25 gM; Sigma Chemical Co., St.  Louis, Mo.),  e-glutamine (20 mM), and 
antibiotics (50  U/ml penicillin, 50 p,g/ml streptomycin). Con A  (5 gg/ml; Pharmacia Fine 
Chemicals, Uppsala, Sweden) was added, and cultures were incubated at 37°C for 48 h  in a 
humidified atmosphere of 5% CO2 in air. Stimulation  was monitored by pulsing sample cultures 
(0.5-1.0  ×  106 cells  in 0.2  ml medium) with [aH]thymidine (2/tCi; New England Nuclear, 
Boston, Mass.)  for 6 h, and measuring isotope uptake. Cultures were harvested, washed three 
times  in phosphate-buffered saline (PBS)  containing methyl a-D-mannopyranoside (0.1 M; 
Sigma Chemical Co.), and resuspended in PBS. 
Immunization.  Each recipient mouse was injected intraperitoneally  with 20 ×  l0  s viable cells 
in 0.5  ml  of an emulsion made  from  equal  volumes of PBS-cell  suspension and complete 
Freund's adjuvant (Difco Laboratories, Detroit, Mich.). Subsequent injections of 15-30 ×  l0  s 
cells in  1 ml PBS were given intraperitoneally at weekly  intervals. Mice were  bled from the 
retro-orbital sinus 1 wk after the sixth and seventh injections. These two bleeds were employed 
throughout this investigation. Serum was stored in aliquots at -80°C. 
Serum Absorption.  Autoantibody in (B10  ×  B10.D2)F1 anti-B10.A(5R) serum was removed 
as follows. Antiserum was diluted  1/5 with PBS and 0.5  ml absorbed three times (1  ×  108 
pelleted spleen plus lymph node cells per absorption, 15 rnin on ice) with B10 and three times 
with  BI0.D2.  For absorption experiments, antiserum depleted of autoantibody was diluted 
1/25 in Hanks' balanced salt solution, and incubated with increasing numbers of lymph node 
cells for 30 min on ice. The cells were then pelleted, and residual cytotoxicity was assayed as 
described. 
Microcytotoxicity Test.  Lymph node cell suspensions  were prepared from the inguinal,  axillary, 694  T-CELL-SPECIFIC  MURINE Ia ANTIGENS 
brachial, cervical, and mesenteric nodes of 8-12-wk-old mice.  Lymph node, spleen, or thymus 
cell  suspensions  were sedimented  on  Ficoll-Hypaque  (Sigma  Chemical  Co.  (30) to remove 
erythrocytes and dead cells. The dye-exclusion microcytotoxicity test  in Terisaki plates (Cooke 
Laboratory Products,  Div.  Dynatech Laboratories  Inc., Alexandria,  Va.)  was performed  as 
described  by Frelinger et  al.  (21),  with  modifications suggested  by D.  B.  Murphy  (personal 
communication).  Briefly,  2 #1 of cell  suspension  (1  ×  106/ml  in  medium with  5% fetal  calf 
serum) was added to 2 #1 of appropriately diluted antiserum, and plates were incubated for 15 
min at 37°C. One drop of medium 199 was then added to each well and the plates were flicked 
after  10 min.  After the addition  of 2 #1 of complement, lysis proceeded for 30 min at  37°C, 
whereupon a drop of nigrosine dye (0.1% in fetal calf serum-containing medium) was added to 
each well. Plates were again flicked after  10 rain, wells were filled with medium (5% fetal  calf 
serum), and the percentage of dead cells was determined.  Rabbit serum, absorbed twice with 
mouse splenocytes (2  ×  108 cells/ml serum) and diluted  1/20 with medium  199 served as the 
source of complement. Complement controls, omitting antiserum, were carried out in quadru- 
plicate for each target cell. Lysis in complement (C') controls was mlO%. Percent of cells lysed 
was calculated according to the formula: 
[ 
% dead experimental  -- % dead C' control] 
% cells lysed  =  100 +  100'~------~  ~  ~7,---~  d--~a--d  C' control  " 
d 
Cell Separation.  Cell suspensions were enriched for T lymphocytes by passage through nylon 
wool columns (Fenwall  Laboratories, Inc., Morton Grove, Ill.)  (31).  Nylon wool-passed cells 
were assayed immediately for Ia antigen expression,  or alternatively, cultured in RPMI-1640 
supplemented with 2.5% fetal calf serum and 25 ~M 2-mercaptoethanol for 12 h at 37°C in a 
humidified  atmosphere  of 5%  CO2  in  air.  To  obtain  a  cell  population  enriched  for  B 
lymphocytes, spleen cells  (30  ×  106/ml  in  RPMI-1640 with  50% fetal  calf serum)  were first 
incubated in plastic dishes  for 1 h at 37°C, transferred to a second set of dishes  for 1 h, and the 
nonadherent cells were collected. T cells were lysed using anti-Thy 1.2 serum (40  ×  10" cells, 
1 ml  serum  diluted  1/30,  generously given by Doctors F-W.  Shen  and  E.  A.  Boyse,  Sloan- 
Kettering Institute for Cancer Research, New York)  and C' (absorbed and diluted as detailed 
above) in a two-step procedure. 
Alloimmunization.  Recipient mice received 2 ×  107 x-irradiated  (2,500 R) donor spleen cells 
in each hind footpad. 3 days later, spleen and lymph nodes (excepting the draining popliteal 
nodes) were excised  and assayed for reactivity with antiserum. 
Results 
Con A  stimulation  of B 10.A(SR)  thymocytes resulted  in a  10-20% recovery of the 
initial  cell number;  20-40% of viable cells were blasts morphologically. The ratio of 
[3H]thymidine uptake  by stimulated  cultures  to that  of controls was usually  ~50:1. 
Recipient (B 10  ×  B 10.D2)F1 mice developed reasonable antibody titers (2,560-5,120) 
against  B10.A(5R)  or  BI0.BR  lymph  node  cells  after  the  sixth  injection  with 
B10.A(5R)  thymocyte blasts.  There  was  considerable  cytotoxicity against  B10  and 
B10.D2  lymph  node cells.  This  was  removed  by absorption  with  B10  and  BI0.D2 
splenocytes and lymph node cells before all further analysis. 
The antiserum, hereafter designated anti-I-JkE  k serum, was titrated in the standard 
dye exclusion microcytotoxicity assay on lymph node, spleen, and thymus cells from 
a  representative haplotype panel. These results are presented in Table II. Only H-2  k, 
H-2  q, and H-2  ~ lymph node cells were lysed to a significant and approximately equal 
(27-30%) extent. Titration on H-2  k splenocytes consistently (five experiments)  gave a 
low degree of lysis  (5.3  +  2% at  dilutions  <1/20).  All other cell populations  tested 
gave  0-5%  lysis.  Lysis  of these  cells  was  variable:  it  was  sometimes  negative  and 
usually <3%. They are represented  as <3% in Table II, and are considered negative. 
Thus, the Ia antigen(s)  detected by this serum are expressed on lymph node cells and 
a  very minor fraction of spleen cells. COLLEEN E.  HAYES AND FRITZ H.  BACtt 
TAaLE II 
Cytotoxicity of (BIO ×  BIO.D2)FI Anti-BIO.A(5R) Serum on a Haplotype 
Panel 
llaplotype  Strain 
Percentage of cells lysed 
Lymph node  Spleen  Thymus 
tt-2 h  B10  <3  ND*  <3 
I I-2  't  B 10.D2  <3  ND  <3 
I I-2  r  B 10.M  <3  <3  <3 
|t-2  k  BI0.BR  27.2 ±  3:[:  5.3 ±  2  <3 
II-2  q  BI0.Q  30  ±  2  <3  <3 
II-2  r  BI0.RIII  <3  ND  <3 
11-2  ~  BI0.S  28  .± 2  <3  <3 
* ND, not determined. 
~: Mean and standard deviation from five experiments. 
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Titration curves for BI0.BR (H-2  k) lymph node and spleen cells are shown in Figs. 
1 A  and  D.  When  these  cell  populations  were specifically enriched  for T  cells  by 
nylon wool passage, and nonadherent cells were assayed immediately, they showed no 
reactivity with anti-I-JkE  k serum (data not shown). If, however, a  12-h culture period 
preceded testing,  the results shown  in  Figs.  1 B  and E  were obtained;  there was no 
significant difference in either percentage of cells lysed (~35-40%), nor antiserum titer 
between nylon wool nonadherent lymph node and spleen cells. Splenic B lymphocytes, 
obtained after removing macrophages by adherence to plastic, and T  lymphocytes by 
anti-Thy 1.2 plus C' treatment, were not reactive with this serum (0-2% lysis), nor did 
they become reactive after a  12-h culture period. Therefore, the antigen(s)  detected 
appear to be expressed only on T  lymphocytes. 
Lymphocytes from  B10.BR  mice  immunized  with  irradiated,  allogeneic  B10.M 
spleen  cells, showed greater reactivity with anti-I-jkE  k serum than  did lymphocytes 
from  normal  mice  (Figs.  1 C  and  F).  Specifically,  antiserum  cytotoxicity  against 
lymph node cells increased from 27  +  3% to 40%, against splenocytes from 5.3  +  2% 
to 20  +  2%. Lymphocytes, activated in a 5-day in vitro allogeneic mixed lymphocyte 
culture, likewise showed increased cytotoxicity with this antiserum (data not shown). 
Furthermore, Con A stimulation of spleen cells induced an increase in percentage of 
spleen cells lysed by antiserum from 5.3  +  2% to 25  +  2%. These results suggest that 
Ia antigen expression was either altered as a result of alloantigen or mitogen activation, 
or that such activation led to the selective expansion of one T-cell subpopulation. 
Anti-I-JkE  k serum contains antibody to the I-E  k subregion.  B10.S-absorbed serum 
lysed ~20% of recombinant B 10.HTT lymph node cells (Fig.  2).  Reaction of recom- 
binant B 10.HTT (I-A"B~J~EkCk) (9, 29) with B 10.S-absorbed serum can be attributed 
to an I-E region-encoded antigen of the H-2  k haplotype, which is not shared by H-2" 
strains  (29).  This  conclusion  was  supported  by  antiserum  reactivity  with  20%  of 
B 10.A(3R)  (I-AbBbJbEkC  d)  (9, 29)  lymph node cells (Fig. 3 A). Because the antiserum 
was  produced  in  (B10  ×  B10.D2)F1  mice  and  absorbed  with  B10  and  B10.D2 
iymphocytes, the antigen detected seems to map within I-E  k. 
(B 10  ×  B10.D2)F1 anti-B10.A(5R)  serum also contains cytotoxic antibody for I-J  k 
subregion-encoded determinants. When the antiserum was absorbed with B 10A.(3R) 
(I-AbBbjbEkC  d)  lymph node cells to remove I-E  k reactivity,  12  +  3% cytotoxicity on 696  T-CELL-SPECIFIC  MURINE Ia ANTIGENS 
I00 
80 
_~  60 
40 
20 
0 
I00 
eo 
60 
4.0 
20 
I00 
80 
--~  60 
40 
20 
A.  BIO.BR  lymph  node  cells 
B.  BIO.BR  nylon  wool.-possed 
lymph  node  cells 
C.  BIO.BR  olloimmune 
lymph  node  cells 
,  J  I  '40  I0  40  640  iO/?. 
Antibody  titer 
D.  BIO.BR  spleen  cells 
--..,,.. 
F.  BIO.BR  nylon  wool-possed 
spleen  cells 
\ 
F.  BIO.BR  olloimmune 
spleen  cells 
I0  40  640  104240 
Antibody  titer 
Fit;.  I.  Cytotoxicity of(Bl0 X BI0.D2)Fj anti-Bl0.A(5R) (anti-l-JkE  k) serum on lymph node and 
spleen cells. Nylon wool-passed cells (B  and  E)  were cultured  12  h  before cytotoxicity assay. 
Alloimmune cells (C and F) were taken 3 days post-immunization with irradiated B 10.M splenocytes 
(see Materials and Methods). Standard deviation was + 10% of the mean. 
B10.BR  lymph  node  cells  remained  (four  experiments;  Fig.  3  B  and  Fig.  4  B). 
Additional absorption did not remove residual antibody. This determinant, therefore, 
appears to map within the I-J  k subregion  (9). 
Absorption studies were conducted to determine if haplotypes H-2  q and H-2" cross- 
react with H-2  k by virtue of I-J  k antibody, I-E  k antibody, or both (Fig. 4). Absorption 
with B 10.BR  (H-2 k) lymph node cells removed cytotoxic antibody for B10.G (H-2q), 
BI0.S  (H-2~),  and  B10.A(3R)  lymph  node  cells  (Fig.  4  A).  However,  B10.A(3R) 
absorption did not remove cytotoxic antibody for B10.S or B10.G lymphocytes (Fig. 
4  B),  nor  did  B10.G  (Fig.  4  C)  or  B10.S  (Fig.  4  D)  absorption  remove  cytotoxic 
antibody for B 10.A(3R) cells. These results suggest that the I-E  k antigen described is 
not  shared  with  haplotypes  H-2  q and  H-2  ~.  Strains  B10.G  and  B10.S  absorb  some 
reactivity  against  BI0.BR  lymph  node cells  indicating  cross-reactivity  with  an  I-J  k COLLEEN  E.  HAYES  AND  FRITZ  H.  BACtt  697 
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Fic. 2.  Cytotoxicity  of BI0.S-absorbed anti-l-JkE  k  on lymph node cells  of recombinant B  I0.HTT. 
Antiserum (100 pl of a 1/5 dilution) was absorbed with B10.S lymph node cells until no further 
activity remained (20 ×  10  ~  cells/absorption, three times). 
subregion  specificity;  residual  lysis  of B10.BR  cells  may  be  attributed  to  an  I-E  k 
subregion antigen(s), or possibly a second I-J  k antigen. 
Discussion 
These experiments illustrate  the production of a  T-cell specific, cytotoxic anti-1- 
JkEk serum using Con A-stimulated thymocyte blasts as immunogen. Con A-stimu- 
lated  lymphoblasts have been used previously for Ia antiserum  production  (28). In 
contrast to the present report, the Ia antiserum described (28) lysed 95% of spleen or 
lymph  node  cells,  exhibited  extensive cross-reactivity with  other  haplotypes,  and 
reacted with  B  lymphocytes as well as T  cells.  G6tze  (28)  employed lymphoblasts 
from spleen and lymph node cells and studied I subregions A, B, J, and E--either or 
both of which may account for the difference in results obtained. 
The induction of anti-I-J  k antibody is not surprising in view of the finding that I-J 
subregion Ia antigens are expressed on Con A-reactive T  cells (29, 32). Moreover, I-E 
specificities have  been  reported on  Con  A-stimulated  thymocytes (29).  That  hi:gh 
titered,  T-cell  specific antiserum  can  be  raised  against  mitogen-stimulated T-cell 
blasts may be due to increased T-cell Ia antigen density on these cells~ or alternatively, 
to selective expansion of that T-cell population which is Ia positive. Thus'it has been 
proposed that activation, either by mitogen or alloantigen, may be required for full 
expression of T-cell Ia determinants (24,  26, 33). The results reported herein sUpport 
this hypothesis. 
The finding that nylon wool-nonadherent cells were not reactive with anti-I-jkE  k 
serum immediately after column passage, but became reactive after  12 h  in.culture 
deserves comment.  Two results  argue  that  the antigens  detected are  probably not 
artifactually introduced as a consequence of culturing. First, lymph node cells taken 
directly from a  donor mouse do not require culturing in order to express antigenic 
determinants.  Second, B cells did not acquire antigenic determinants after  12 h  in 
culture. If T-cell Ia antigens are adherent to nylon wool and are readily shed from the 
cellular membrane, it is possible that nylon wool columns may strip Ia antigens from 
the T-cell surface. This would convert Ia-positive cells into Ia-negative cells; a period 
of time in culture would then permit resynthesis and/or reexpression of these antigens. 698  T-CELL-SPECIFIC MURINE la ANTIGENS 
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FIG. 3.  Cytotoxicity  of anti-I-JkE  k serum on BI0.A(3R) and B10.BR lymph node cells. Serum 
reactivity before absorption, (Q); after twice absorbing 50 p.I of 1/5 diluted serum with 20 ×  10" 
BI0.A(3R) lymph node cells, (O). 
The conversion of Ia positive to negative cells by nylon wool-column passage has been 
suggested previously (21, 23). 
Since  (B10  ×  B10.D2)F1  recipient  mice  (TL.2)  differed from  B10.A(5R)  donor 
mice (TL. 1, 2, 3, 5) at the Tla locus, and TL antigens are expressed on thymocytes, 
the possibility of anti-TL antibody must be considered (34-36). TL antigens are not 
expressed on lymph node cells (34), with which this antiserum reacts most strongly. 
Moreover, BI0.HTT carries the same Tla allele as B10.D2. Therefore, the anti-I-E 
activity measured cannot be due to TL activity. Likewise, anti-I-J activity cannot be 
attributed to TL; B10.A(3R)-absorbed serum was tested on TL- B10.BR cells. 
A second T-cell antigen, Qa-1, might also have elicited antibody (37). B10.A(5R), 
derived from B10.A (Qa-l+), differs at this locus from B10 and B10.D2 (both Qa-1-) 
(37). However, test strains B10.HTT and BI0.BR (Qa-1-) cannot react by virtue of 
the Qa-1  antigen,  indicating that  the specificities detected are not products of this 
locus. B10.D2, B10, and B10.A recombinant B10.A(5R) share the Qa-2 allele, ruling 
out products of this locus having elicited antibody (38). To determine whether the 
antiserum contains antibody or other H-2-1inked antigens will require further exper- 
imentation. 
The I-J subregion of H-2, marked by locus Ia-4, controls antigenic determinants 
expressed on a subclass of T  lymphocytes, suppressor T  cells (9, 39). These determi- 
nants are not present on B lymphocytes (9, 39). Ahhough suppressive function may 
be abolished by anti-I-J serum plus C', conventional cytotoxicity assays have failed to 
demonstrate I-J antigens on either spleen or lymph node cells (9, 35). Thus, Murphy COLLEEN  E.  HAYES  AND  FRITZ  H.  BACH  699 
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Fro. 4.  Absorption of anti-l-JkE  k serum with BI0.BR, BI0.A(3R), BI0.G, and B10.S lymph node 
cells.  Experimental details are  described in  Materials and  Methods. BI0.BR,  (0);  BI0.A(3R), 
(O); BI0.C, (&); BI0.S, (/x). 
et  al.  (9)  estimated  that  I-J-bearing  cells comprise <10%  of spleen  or lymph  node 
lymphocytes. Parish and McKenzie (40), employing a rosetting assay, suggested that 
8% of Ig- splenocytes displayed I-J specificities. Finally, Okuda et al.  (41) estimated 
that  10% of nylon wool-nonadherent  lymph  node cells express the I-J determinant. 
Although  no  estimate  of the  percentage  of I-E  positive  T  cells  was  given,  these 
determinants  were weakly expressed  on some T  cells  (29).  Unlike  these previously 
described  antisera,  the  antiserum  described  herein  is  very clearly  cytotoxic  for  T 
lymphocytes  from  lymph  node  and  spleen;  35-40%  of  nylon  wool-nonadherent 
lymphocytes were lysed by anti-I-JkE k serum plus C'. This is a far higher proportion 
than  that found in prior studies (9, 29, 39-41). Considering the results obtained with 
lymph node cells (27% lysed by anti-I-JkEk;  10% lysed by anti-I-Jk;  20% lysed by anti- 700  T-CELL-SPECIFIC MURINE la  ANTIGENS 
I-Ek),  it  appears  possible  that  those  cells  expressing  I-J  k  specificities  and  those 
expressing I-E  k determinants may be nonoverlapping T-cell subsets. Okuda et al. (41) 
suggested  that  I-J-positive and  I-E-positive cells were  included  in  the same  T-cell 
subset. 
In the present report, the assignment of an Ia specificity to the I-E subregion of H- 
2 is based on the assumption that strain B 10.A (from which B 10.A(3R) and B 10.A(5R) 
were derived) carries the Ia-3  d rather than the Ia-3  k allele (29).  If this is not the case 
(B10.A carries  the  I-C  subregion  of the  k  parent),  the specificity described herein 
might well be an I-C rather than I-E subregion-encoded antigen (42). Assuming that 
B10.A carries I-C  d,  the specificity described in  this report may be Ia.22  (29).  This 
antigen  was  reportedly  expressed  on  thymocyte  blasts;  however,  Ia.22  was  also 
detected on  lipopolysaccharide blasts  (29).  The  authors  concluded  that  Ia.22  was 
predominantly expressed on B cells (29).  In the present report, unstimulated B cells 
did  not  react  with  anti-I-JkE  k serum.  Thus,  it  is  not  clear on  the  basis  of cellular 
expression whether the  antigen  described is  Ia.22.  It  is  noteworthy that  an  anti-1- 
AkBkjkE  k serum lysed T  but not B lymphocytes of strain B 10.HTT (I-A~BSJ~E  k) (25). 
There are  two  possible  interpretations of this  result.  Either anti-I-AkBkjkE  k serum 
reacted with B 10.HTT T  cells by virtue of an I-Ek-encoded antigen expressed only on 
T  cells, in which case the result supports our finding, or T-cell lysis was due to cross- 
reactivity between I-ASBSJ  ~ of B 10.HTT and I-AkBkjkE  k of AQR  (against which the 
serum  was  produced). The I-E-region specificity described in  the present  report  is 
unique to the H-2  k haplotype, as is Ia.22 (29). 
The  finding  that  an  I-JkE  k serum,  raised  against  Con  A-stimulated  thymocyte 
blasts, does not react with B lymphocytes has important implications for Ia antigen 
serology, as  well  as  studies  of Ia antigen  expression on  functionally distinct  T-cell 
subpopulations. This result suggests that a group of I region-encoded antigens, unique 
to T  lymphocytes, may not have been detected because they would have comprised 
only  a  minor  antigenic  component  in  conventional  immunization  protocols  (skin 
grafting and/or spleen and lymph node cell immunization), in contrast to the B-cell 
Ia antigens. If this is the case, T cells that have been described as Ia negative (cytotoxic 
T  lymphocytes  (43),  T  lymphocytes mediating  delayed  hypersensitivity  (44),  and 
others)  may  express  Ia  antigens  not  yet  described.  Experiments  examining  this 
question are in progress. Conceptually, the demonstration of Ia determinants associ- 
ated with different subregions of H-2 I, and present on substantial percentages of the 
T  lymphocytes in  lymph  nodes and  spleens  (with  different determinants probably 
present on different cell populations), establishes another potential link between Ia 
antigens  and  T-lymphocyte immune  response  function.  Although  these  data  are 
consistent with the hypothesis that  molecules (or lymphocytes) carrying Ia determi- 
nants play a role in immunoregulatory communication among lymphocytes, a direct 
confirmation of this hypothesis awaits further exploration. 
Summary 
(B10  ×  B10.D2)F1 mice were immunized with BI0.A(5R) concanavalin A-stirnu- 
lated  thymocyte  blasts.  The  genetic  disparity  between  donor  and  recipient  was 
restricted to the I-J and I-E subregions of the murine major histocompatibility (H-2) 
complex. A high-titered, T-cellrspecific anti-I-JkE  k serum was obtained. The antiserum 
lysed 27-30% of haplotype k, q, or s lymph node cells, ,5.3 __+ 2% ofhaplotype k spleen COLLEEN E.  ttAYES AND FRITZ H.  BACtt  701 
cells, and did not lyse thymocytes. Nylon wool-passed lymph node or spleen cells (H- 
2  k) showed considerable reactivity with anti-I-JkE  k serum (35-40% lysis); anti-Thyl.2 
plus  complement-treated spleen  cells did not  react  (<5%  lysis).  I-E  k antibody was 
detected by B I0.A(3R)  lymph node cell reactivity (20% lysis), whereas reaction with 
H-2  k lymph node cells after B10.A(3R)  absorption demonstrated I-J  k antibody (12% 
lysis). Lymphocyte activation with alloantigen or mitogen led to increased anti-I-JkE  k 
serum reactivity. These results, showing antibody production to at least two T-cell Ia 
antigenic  determinants  by concanavalin  A  thymocyte blast  immunization,  suggest 
that a group of I-region-encoded T-cell specificities may not have been detected using 
conventional immunization protocols because they would not have comprised a major 
antigenic component of the immunizing cell population. The existence of multiple Ia 
antigenic determinants unique to T  lymphocytes would have important implications 
for serological and functional studies of T-cell subpopulations. 
The authors wish to extend their gratitude to Mr. Robert Ehlenfeldt, who carefully supervised 
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assistance  in preparing this manuscript. 
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